You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Treatments available
Although it can be a long road, solutions are available, and each patient can benefit from a therapy adapted to his or her symptoms.
When overactive bladder (OAB) incontinence is secondary to a cause, the cause must of course be treated.
When it is idiopathic, the following treatments are proposed as first-line therapy1:
This involves adjusting diet and fluid intake. It is recommended to cut down on beverages if they are consumed in excessive quantities, and to limit coffee and tea, which encourage urgency. Losing a little weight can also help.
Consists of various exercises designed to improve sphincter strength and bladder control.
These are usually drugs in the anticholinergic class. Their role is to block the action of acetylcholine, a neurotransmitter involved in bladder contractions.
These are performed at several points in the bladder wall. Their goal is to reduce uncontrolled bladder contractions and urgency by acting on nerve endings in the bladder wall. This treatment is not permanent and will need to be repeated over time.
This treatment uses a low-intensity electrical current to stimulate the sacral nerves, which play an important role in controlling the urinary and fecal systems. The treatment can be tested by the patient and is reversible.
EAU Guidelines on non-neurogenic female LUTS: https://uroweb.org/guidelines/non-neurogenic-female-luts
The information presented on this website is for information purposes only. It is not intended to replace a consultation with a healthcare professional.